Brief: Tenax Therapeutics Q3 Net Income USD -15.804 Million
Nov 12 (Reuters) - Tenax Therapeutics Q3 operating expenses USD 16.806 million. Q3 operating income USD -16.806 million
Nov 12 (Reuters) - Tenax Therapeutics Q3 operating expenses USD 16.806 million. Q3 operating income USD -16.806 million